About Accelovance
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Accelovance
During the past decade, Accelovance conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Accelovance"
#1 collaborator was "King Pharmaceuticals is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Accelovance
According to Clinical.Site data, the most researched conditions in "Accelovance" are
"Nocturia" (2 trials), "Bacillus Anthracis (Anthrax)" (1 trials), "Benign Prostatic Hyperplasia" (1 trials) and "Sexual Arousal Disorder" (1 trials). Many other conditions were trialed in "Accelovance" in a lesser frequency.
Clinical Trials Intervention Types at Accelovance
Most popular intervention types in "Accelovance" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "AVA" (1 trials), "Bremelanotide" (1 trials), "Desmopressin Melt" (1 trials), "Lonidamine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Accelovance
The vast majority of trials in "Accelovance" are
3 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Accelovance
Currently, there are NaN active trials in "Accelovance".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Accelovance,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Accelovance, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".